5R11

PanDDA analysis group deposition -- Auto-refined data of Aar2/RNaseH for ground state model 15, DMSO-free

5R11 の概要

• エントリーDOI: 10.2210/pdb5r11/pdb
• Group deposition: PanDDA analysis of F2X-Entry Screen vs. Aar2/RNaseH, DMSO-free soaking (G_1002119)
• 分子名称: Pre-mRNA-splicing factor 8, A1 cistron-splicing factor AAR2 (3 entities in total)
• 機能のキーワード: fragmax, fragmaxapp, fragment screening, rnaseh like domain, vhs like domain, u5 snrnp assembly, splicing
• 由来する生物種: Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast); 詳細
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 65710.95

構造登録者

Wollenhaupt, J.,Metz, A.,Barthel, T.,Lima, G.M.A.,Heine, A.,Mueller, U.,Klebe, G.,Weiss, M.S. (登録日: 2020-02-12, 公開日: 2020-06-03, 最終更新日: 2024-03-06)

主引用文献

Wollenhaupt, J.,Metz, A.,Barthel, T.,Lima, G.M.A.,Heine, A.,Mueller, U.,Klebe, G.,Weiss, M.S.
F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure, 28:694-706.e5, 2020

PubMed Abstract: Crystallographic fragment screening (CFS) provides excellent starting points for projects concerned with drug discovery or biochemical tool compound development. One of the fundamental prerequisites for effective CFS is the availability of a versatile fragment library. Here, we report on the assembly of the 1,103-compound F2X-Universal Library and its 96-compound sub-selection, the F2X-Entry Screen. Both represent the available fragment chemistry and are highly diverse in terms of their 3D-pharmacophore variations. Validation of the F2X-Entry Screen in CFS campaigns using endothiapepsin and the Aar2/RNaseH complex yielded hit rates of 30% and 21%, respectively, and revealed versatile binding sites. Dry presentation of the libraries allows CFS campaigns to be carried out with or without the co-solvent DMSO present. Most of the hits in our validation campaigns could be reproduced also in the absence of DMSO. Consequently, CFS can be carried out more efficiently and for a wider range of conditions and targets.

PubMed: 32413289
DOI: 10.1016/j.str.2020.04.019

実験手法

X-RAY DIFFRACTION (1.82 Å)